Melissa Lezameta is a Senior Associate at Epidarex Capital with experience in technology translation and business development across life science institutions and companies.
What Melissa can write
Career
- Geron Inc · Postdoc
- Campbell Alliance (now Syneos Health) · Consultant Associate
- University of California San Francisco’s (UCSF) office of Innovation, Technology and Alliances · Licensing Officer
- Nanomolar Inc · Director of Business Development
- Cancer Research UK · Translation Executive
- Crick Institute, London · Senior Business Manager
- Epidarex Capital · Senior AssociateNow
Focus
Education
Also at Epidarex Capital
Partners like Melissa
At firms with a similar stage, sector and check size.
Alert me when Epidarex Capital is active
One email when Melissa's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Melissa Lezameta?
Melissa Lezameta is a Senior Associate at Epidarex Capital with experience in technology translation and business development across life science institutions and companies.
How much does Melissa Lezameta invest?
Epidarex Capital has not reported a check size. It invests at seed, series a.
How do I pitch Melissa Lezameta?
Email [email protected], the firm's inbox for founders, and name Melissa in the subject. A warm intro from a founder Epidarex Capital backed works better.
What did Melissa Lezameta do before Epidarex Capital?
Postdoc at Geron Inc; Consultant Associate at Campbell Alliance (now Syneos Health); Licensing Officer at University of California San Francisco’s (UCSF) office of Innovation, Technology and Alliances; Director of Business Development at Nanomolar Inc; Translation Executive at Cancer Research UK; Senior Business Manager at Crick Institute, London.
Last updated 2026-10-15. Is this you? Ask for a correction.